Target intelligence / Profile preview

Melanosome transfer

Molecular classification
Other (Biological process; not a molecule, receptor, enzyme, or canonical drug target)
01

Overview

Melanosome transfer refers to the process by which melanin-containing organelles, **melanosomes**, are transferred from pigment-producing melanocytes to neighboring keratinocytes in the skin and hair follicles[1][2][3][7]. Multiple mechanisms have been proposed for this transfer, including cytophagocytosis of dendritic tips, direct membrane fusion, exocytosis of melanosome cores followed by endocytosis, and the shedding-phagocytosis of vesicles or globules containing melanosomes[1][2][3][4]. Melanosome transfer is essential for visible skin and hair pigmentation and for photoprotection, as melanin caps keratinocyte nuclei to protect DNA from UV-induced damage, thereby reducing skin cancer risk[1][5]. Molecular regulators and cytoskeletal elements (e.g., Rab27A-melanophilin-Myosin Va complex, RhoA, Rac1, PKA, PKC, and certain autophagy proteins) facilitate the transport and transfer processes, but **"melanosome transfer" itself is not a druggable molecular entity**[2][3][6]. Dysfunction in this process can cause pigmentary diseases but no drugs directly interact with "melanosome transfer" as a molecular target. In summary, "melanosome transfer" should not be treated as a canonical molecular or therapeutic target, but as a complex, multi-step intercellular biological process[1][2][3][4][5][7].

Other names
Pigment organelle transferMelanin transferIntercellular melanosome transfer
02

Biological functions

Skin pigmentationPhotoprotectionMelanin distributionOrganellar transport
03

Disease associations

Pigmentary disorders (e.g., vitiligo, albinism)Skin cancer (protective role in melanin shielding DNA)Other disorders related to abnormal pigmentation

Beyond the preview

Go deeper on Melanosome transfer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanosome transfer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call